These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 16291713)
1. Bioavailability and metabolism of prochlorperazine administered via the buccal and oral delivery route. Finn A; Collins J; Voyksner R; Lindley C J Clin Pharmacol; 2005 Dec; 45(12):1383-90. PubMed ID: 16291713 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of prochlorperazine buccal tablets (Bukatel) and metoclopramide oral tablets in the treatment of acute emesis. Singh S; Sharma DR; Chaudhary A J Indian Med Assoc; 1999 Aug; 97(8):346-7. PubMed ID: 10643185 [TBL] [Abstract][Full Text] [Related]
3. Comparison of buccal and oral prochlorperazine in the treatment of dizziness associated with nausea and/or vomiting. Bond CM Curr Med Res Opin; 1998; 14(4):203-12. PubMed ID: 9891192 [TBL] [Abstract][Full Text] [Related]
4. Studies of prochlorperazine as a buccal tablet (Buccastem) and an oral tablet (Stemetil) for the treatment of dizziness, nausea or vomiting in a general practice setting. Ward AE Br J Clin Pract; 1988 Jun; 42(6):228-32. PubMed ID: 3061429 [No Abstract] [Full Text] [Related]
5. Clinical pharmacology of prochlorperazine in healthy young males. Isah AO; Rawlins MD; Bateman DN Br J Clin Pharmacol; 1991 Dec; 32(6):677-84. PubMed ID: 1768559 [TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics and bioavailability of prochlorperazine delivered as a thermally generated aerosol in a single breath to volunteers. Avram MJ; Spyker DA; Henthorn TK; Cassella JV Clin Pharmacol Ther; 2009 Jan; 85(1):71-7. PubMed ID: 18830225 [TBL] [Abstract][Full Text] [Related]
7. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers. Darwish M; Tempero K; Kirby M; Thompson J Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo characteristics of prochlorperazine oral disintegrating film. Nishimura M; Matsuura K; Tsukioka T; Yamashita H; Inagaki N; Sugiyama T; Itoh Y Int J Pharm; 2009 Feb; 368(1-2):98-102. PubMed ID: 18992311 [TBL] [Abstract][Full Text] [Related]
9. Recirculatory pharmacokinetic model of the uptake, distribution, and bioavailability of prochlorperazine administered as a thermally generated aerosol in a single breath to dogs. Avram MJ; Henthorn TK; Spyker DA; Krejcie TC; Lloyd PM; Cassella JV; Rabinowitz JD Drug Metab Dispos; 2007 Feb; 35(2):262-7. PubMed ID: 17079359 [TBL] [Abstract][Full Text] [Related]
10. Disposition and metabolism of radiolabeled casopitant in humans. Pellegatti M; Bordini E; Fizzotti P; Roberts A; Johnson BM Drug Metab Dispos; 2009 Aug; 37(8):1635-45. PubMed ID: 19420128 [TBL] [Abstract][Full Text] [Related]
11. Verapamil disposition and effect on PQ-intervals after buccal, oral and intravenous administration. Asthana OP; Woodcock BG; Wenchel M; Frömming KH; Schwabe L; Rietbrock N Arzneimittelforschung; 1984; 34(4):498-502. PubMed ID: 6540109 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamic action of budesonide after buccal administration in healthy subjects and patients with oral chronic graft-versus-host disease. Dilger K; Halter J; Bertz H; Lopez-Lazaro L; Gratwohl A; Finke J Biol Blood Marrow Transplant; 2009 Mar; 15(3):336-43. PubMed ID: 19203724 [TBL] [Abstract][Full Text] [Related]
13. Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy. Morgan RJ; Synold T; Carr BI; Doroshow JH; Womack EP; Shibata S; Somlo G; Raschko J; Leong L; McNamara M; Chow W; Tetef M; Margolin K; Akman S; Longmate J Cancer Chemother Pharmacol; 2001 Apr; 47(4):327-32. PubMed ID: 11345649 [TBL] [Abstract][Full Text] [Related]
14. [Diagnostic image (17). Acute dystonia induced by prochlorperazine]. van Gijn J Ned Tijdschr Geneeskd; 2000 Dec; 144(52):2496. PubMed ID: 11155505 [TBL] [Abstract][Full Text] [Related]
15. Provesicular granisetron hydrochloride buccal formulations: in vitro evaluation and preliminary investigation of in vivo performance. Ahmed S; El-Setouhy DA; El-Latif Badawi AA; El-Nabarawi MA Eur J Pharm Sci; 2014 Aug; 60():10-23. PubMed ID: 24793896 [TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of maropitant, a novel neurokinin type-1 receptor antagonist, in dogs. Benchaoui HA; Cox SR; Schneider RP; Boucher JF; Clemence RG J Vet Pharmacol Ther; 2007 Aug; 30(4):336-44. PubMed ID: 17610407 [TBL] [Abstract][Full Text] [Related]
17. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728 [TBL] [Abstract][Full Text] [Related]
18. Comparison of metoclopramide, prochlorperazine and placebo in prevention of postoperative nausea and vomiting (PONV) following tonsillectomy in young adults. Jamil M; Gilani SM; Khan SA J Ayub Med Coll Abbottabad; 2005; 17(4):40-4. PubMed ID: 16599033 [TBL] [Abstract][Full Text] [Related]
19. Use of the buccal route for the administration of an antiemetic. Patterson KW; Keane PW Anesth Analg; 1992 Jun; 74(6):937-8. PubMed ID: 1595936 [No Abstract] [Full Text] [Related]
20. Indomethacin/prochlorperazine/caffeine: a review of its use in the acute treatment of migraine and in the treatment of episodic tension-type headache. Hoy SM; Scott LJ CNS Drugs; 2011 Apr; 25(4):343-58. PubMed ID: 21425885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]